The Surgical Management of Intracranial Metastasis Secondary to Follicular Cell‐Derived Thyroid Carcinoma

Victoria Harries,Alana Eagan,R. Michael Tuttle,Ashok R. Shaha,Richard J. Wong,Jatin P. Shah,Snehal G. Patel,Cameron Brennan,Ian Ganly
DOI: https://doi.org/10.1002/jso.27883
2024-09-29
Journal of Surgical Oncology
Abstract:Background Intracranial metastases (ICM) from follicular cell‐derived thyroid carcinoma (FCDTC) are rare and are associated with a poor prognosis. The objective of this study is to report our experience in the surgical management of patients with ICM secondary to FCDTC. Methods Patients with FCDTC who underwent surgical resection of an ICM were identified at our institution from 1998 to 2018. Results Thirty‐two patients were included in this study. Nineteen patients (59%) had involvement of the brain parenchyma only, 8 (25%) had a dural‐based metastasis, 3 (9%) had a calvarial metastasis with dural extension, and 2 (6%) had a skull base metastasis with dural extension. In patients who had an R0‐1 resection, the estimated lesional control at the site of resection was 91% at 3 years. However, overall ICM control was 37% at 3 years due to the progression of other ICM lesions. The 1‐year disease‐specific survival (DSS) was 87% and 5‐year DSS was 37%. Conclusions ICM management in FCDTC is based on the size, number, and location of metastatic lesions. Complete resection of ICM may provide lesional control at the site of resection, however, DSS is poor due to the presence of other ICMs and metastases at multiple distant sites.
oncology,surgery
What problem does this paper attempt to address?